Genotype and Phenotype Heterogeneity in Perrault Syndrome

2013 ◽  
Vol 26 (1) ◽  
pp. e25-e27 ◽  
Author(s):  
Min Jeong Kim ◽  
Sa Jin Kim ◽  
Jiyeon Kim ◽  
Hyojin Chae ◽  
Myungshin Kim ◽  
...  
Neurogenetics ◽  
2021 ◽  
Author(s):  
Antonia Maletzko ◽  
Jana Key ◽  
Ilka Wittig ◽  
Suzana Gispert ◽  
Gabriele Koepf ◽  
...  

AbstractMitochondrial dysfunction may activate innate immunity, e.g. upon abnormal handling of mitochondrial DNA in TFAM mutants or in altered mitophagy. Recent reports showed that also deletion of mitochondrial matrix peptidase ClpP in mice triggers transcriptional upregulation of inflammatory factors. Here, we studied ClpP-null mouse brain at two ages and mouse embryonal fibroblasts, to identify which signaling pathways are responsible, employing mass spectrometry, subcellular fractionation, immunoblots, and reverse transcriptase polymerase chain reaction. Several mitochondrial unfolded protein response factors showed accumulation and altered migration in blue-native gels, prominently the co-chaperone DNAJA3. Its mitochondrial dysregulation increased also its extra-mitochondrial abundance in the nucleus, a relevant observation given that DNAJA3 modulates innate immunity. Similar observations were made for STAT1, a putative DNAJA3 interactor. Elevated expression was observed not only for the transcription factors Stat1/2, but also for two interferon-stimulated genes (Ifi44, Gbp3). Inflammatory responses were strongest for the RLR pattern recognition receptors (Ddx58, Ifih1, Oasl2, Trim25) and several cytosolic nucleic acid sensors (Ifit1, Ifit3, Oas1b, Ifi204, Mnda). The consistent dysregulation of these factors from an early age might influence also human Perrault syndrome, where ClpP loss-of-function leads to early infertility and deafness, with subsequent widespread neurodegeneration.


2016 ◽  
Vol 91 (2) ◽  
pp. 302-312 ◽  
Author(s):  
L.A.M. Demain ◽  
J.E. Urquhart ◽  
J. O'Sullivan ◽  
S.G. Williams ◽  
S.S. Bhaskar ◽  
...  
Keyword(s):  

2020 ◽  
Vol 11 (12) ◽  
pp. 866-880 ◽  
Author(s):  
Xin Shao ◽  
Xiaoyan Lu ◽  
Jie Liao ◽  
Huajun Chen ◽  
Xiaohui Fan

AbstractFor multicellular organisms, cell-cell communication is essential to numerous biological processes. Drawing upon the latest development of single-cell RNA-sequencing (scRNA-seq), high-resolution transcriptomic data have deepened our understanding of cellular phenotype heterogeneity and composition of complex tissues, which enables systematic cell-cell communication studies at a single-cell level. We first summarize a common workflow of cell-cell communication study using scRNA-seq data, which often includes data preparation, construction of communication networks, and result validation. Two common strategies taken to uncover cell-cell communications are reviewed, e.g., physically vicinal structure-based and ligand-receptor interaction-based one. To conclude, challenges and current applications of cell-cell communication studies at a single-cell resolution are discussed in details and future perspectives are proposed.


2021 ◽  
Vol 25 (8) ◽  
pp. 528-539
Author(s):  
Amal Souissi ◽  
Mariem Ben Said ◽  
Fakher Frikha ◽  
Ines Elloumi ◽  
Saber Masmoudi ◽  
...  

Author(s):  
Chenhui Mao ◽  
Liling Dong ◽  
Jie Li ◽  
Xinying Huang ◽  
Dan Lei ◽  
...  

PLoS Genetics ◽  
2019 ◽  
Vol 15 (11) ◽  
pp. e1008432 ◽  
Author(s):  
Alex Diaz-Papkovich ◽  
Luke Anderson-Trocmé ◽  
Chief Ben-Eghan ◽  
Simon Gravel

2016 ◽  
Author(s):  
Luis Almeida ◽  
Rebecca Chisholm ◽  
Jean Clairambault ◽  
Alexandre Escargueil ◽  
Tommaso Lorenzi ◽  
...  

2020 ◽  
Vol 10 (1) ◽  
Author(s):  
You Na Kim ◽  
Joon Seon Song ◽  
Seak Hee Oh ◽  
Yoon Jeon Kim ◽  
Young Hee Yoon ◽  
...  

Abstract Due to the genotype–phenotype heterogeneity in retinitis pigmentosa (RP), molecular diagnoses and prediction of disease progression is difficult. This study aimed to report ocular and genetic data from Korean patients with PDE6B-associated RP (PDE6B-RP), and establish genotype–phenotype correlations to predict the clinical course. We retrospectively reviewed targeted next-generation sequencing or whole exome sequencing data for 305 patients with RP, and identified PDE6B-RP in 15 patients (median age, 40.0 years). Amongst these patients, ten previously reported PDE6B variants (c.1280G > A, c.1488del, c.1547T > C, c.1604T > A, c.1669C > T, c.1712C > T, c.2395C > T, c.2492C > T, c.592G > A, and c.815G > A) and one novel variant (c.712del) were identified. Thirteen patients (86.7%) experienced night blindness as the first symptom at a median age of 10.0 years. Median age at diagnosis was 21.0 years and median visual acuity (VA) was 0.20 LogMAR at the time of genetic analysis. Nonlinear mixed models were developed and analysis revealed that VA exponentially decreased over time, while optical coherence tomography parameters linearly decreased, and this was related with visual field constriction. A high proportion of patients with the c.1669C > T variant (7/9, 77.8%) had cystoid macular edema; despite this, patients with this variant did not show a higher rate of functional or structural progression. This study will help clinicians predict functional and structural progression in patients with PDE6B-RP.


Author(s):  
Michael E. Gottschalk ◽  
Steven B. Coker ◽  
Larry A. Fox
Keyword(s):  

Sign in / Sign up

Export Citation Format

Share Document